PTC Therapeutics Inc Capital Reinvestment Ratio
PTC Therapeutics Inc capital reinvestment ratio. PTC Therapeutics Inc (PTCT) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($870.10 Million) in capital expenditures ($2.53 Million). See PTC Therapeutics Inc (PTCT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of PTC Therapeutics Inc (2025–2025)
Capital reinvestment ratio of PTC Therapeutics Inc from 2025 to 2025. This chart tracks PTC Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. See PTC Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
PTC Therapeutics Inc Capital Reinvestment Ratio by Year (2025–2025)
PTC Therapeutics Inc capital reinvestment ratio by year from 2025 to 2025. For the full cash flow conversion analysis, see PTC Therapeutics Inc (PTCT) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $711.20 Million | $8.86 Million | — |